Director, Interventional Radiology, Warren Alpert Medical School of Brown University. Former IR @MSKCancerCenter Trained @WeillCornell_IR @LaheyRadiology
New @AJR_Radiology Accepted Manuscript:
"Image-Guided Thermal Ablation in Patients With Locally Recurrent Non-Small Cell Lung Cancer After Stereotactic-Beam Radiation Therapy"
By Drs Mai, Kim, & team @BrownMedicine
https://t.co/jbu6rqfcrR
The American Cancer Society was a natural choice for my fundraiser, not just because of my work but also because of my thoughts regarding running and the cancer journey. Please consider contributing, not for me but for those who are facing cancer.
That's right! @Brown_VIR finished strong @BAA Boston Half! Back to work tomorrow! Hope we have a bigger team to get our team t-shirt next year! Great run @amandaradVIRRN!
Only few hours left to support. My wicked smaht oncologist friend, Wungki Park @W_Park_MD is running NYC full marathon this year! Let us show some last minute support! https://t.co/qfhAuNcCQv
Please help me reach my fundraising goals for the 2022 TCS New York City Marathon Fundraising!
Day in day out. I've been running and will continue to run for my goals. Thank you for your kind donation. 🥰
https://t.co/DInvrzwDXa
SIO has submitted updates to the NCCN Soft Tissue Sarcoma Panel. Submitted by Jack Jennings, MD, PhD, Joseph Erinjeri, MD, PhD and Daehee Kim, MD. View the full letter here: https://t.co/lPfSSIpCX4 #NCCN#Sarcoma
@TiaForsman@Brown_VIR@SIRRFS@nicole_jisoo Congratulations on this splendid work! Was a great pleasure to work with this extremely talented group. So proud of you guys!
Super honored to represent @Brown_VIR and take FIRST PLACE 🏆in the @SIRRFS Biodesign competition at #SIR2022 with @nicole_jisoo ! We are developing a palliative care + IR patient companion application! Keep an eye out for #DrainPal
We are excited to announce positive topline results from our Phase 3 DeFi trial, which is evaluating our investigational gamma secretase inhibitor in adults with progressing #desmoid tumors. Read more: https://t.co/zD3djyWoNk
We now have a new tool in our armamentarium tackling #Desmoid. It is not for everyone and needs more studies and collaboration but is very promising for this perplexing yet benign disease! https://t.co/DKuIBYCAC3, https://t.co/wa9vdw9rdo,
@DTRFoundation@DesmoidI